Skip to main content
Log in

QOL Impact of ‘Neoral’ use in Patients with Psoriasis

  • This Month’s News
  • Published:
Disease Management & Health Outcomes

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • QOL impact of ‘Neoral’ use in patients with psoriasis. Pharmacoeconomics Outcomes News 1997 Jul 12; 120: 10

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

QOL Impact of ‘Neoral’ use in Patients with Psoriasis. Dis-Manage-Health-Outcomes 2, 157 (1997). https://doi.org/10.2165/00115677-199702030-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00115677-199702030-00007

Navigation